ATLAS / Macro Radar / Reporting / BBIO

BridgeBio Pharma, Inc. (BBIO) reporting calendar

BridgeBio Pharma, Inc. files periodic reports with the SEC as BBIO on Nasdaq. Atlas tracks 28 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 18 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
28

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BBIO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001743881-26-000019
10-K31 Dec 202524 Feb 202655 days0001743881-26-000009
10-Q30 Sep 202529 Oct 202529 days0001743881-25-000012
10-Q30 Jun 20255 Aug 202536 days0000950170-25-103192
10-Q31 Mar 202529 Apr 202529 days0000950170-25-060314
10-K31 Dec 202420 Feb 202551 days0000950170-25-024119
10-Q30 Sep 202412 Nov 202443 days0000950170-24-124577
10-Q30 Jun 20241 Aug 202432 days0000950170-24-089326
10-Q31 Mar 20242 May 202432 days0000950170-24-052165
10-K31 Dec 202322 Feb 202453 days0000950170-24-018811
10-Q30 Sep 20232 Nov 202333 days0000950170-23-058255
10-Q30 Jun 20233 Aug 202334 days0000950170-23-037977
10-Q31 Mar 20234 May 202334 days0000950170-23-017812
10-K31 Dec 202223 Feb 202354 days0000950170-23-004145
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021936
10-Q30 Jun 20224 Aug 202235 days0000950170-22-014824
10-Q31 Mar 20225 May 202235 days0000950170-22-007874
10-K31 Dec 202125 Feb 202256 days0000950170-22-002030
10-Q30 Sep 20214 Nov 202135 days0000950170-21-003080
10-Q30 Jun 20215 Aug 202136 days0001564590-21-041676
10-Q31 Mar 20216 May 202136 days0001564590-21-025064
10-K31 Dec 202025 Feb 202156 days0001564590-21-008969
10-Q30 Sep 20205 Nov 202036 days0001564590-20-051460
10-Q30 Jun 202011 Aug 202042 days0001564590-20-039358
10-Q31 Mar 202014 May 202044 days0001564590-20-025197
10-K31 Dec 20193 Mar 202063 days0001564590-20-008260
10-Q30 Sep 20198 Nov 201939 days0001564590-19-041986
10-Q30 Jun 201914 Aug 201945 days0001564590-19-031927

Source: SEC EDGAR company submissions for CIK 0001743881. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.